Report Detail
Global Renin-Inhibitors Market Growth 2019-2024
- RnM2996293 |
- 21 February, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the kidneys in response to sympathetic activation, hypotension, and decreased sodium delivery to the distal renal tubule. Aliskiren (INN) (trade names Tekturna, US; Rasilez, UK and elsewhere) is the first in a class of drugs called direct renin inhibitors. Its current licensed indication is essential (primary) hypertension.
USA is still the largest consumption region of Tekturna, occupied about 56% market share globally, with revenue 39.21 million USD in 2017. At the same time, Asia will see the considerable growth since Noden Pharma DAC had successfully entered into an agreement with Orphan Pacific (Japan) and Lee’s Pharmaceutical Holdings Limited (China).
According to this study, over the next five years the Renin-Inhibitors market will register a 5.6% CAGR in terms of revenue, the global market size will reach US$ 100 million by 2024, from US$ 69 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Renin-Inhibitors business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Renin-Inhibitors market by product type, application, key manufacturers and key regions and countries.
This study considers the Renin-Inhibitors value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
150mg/Tablet
300mg/Tablet
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Age below 45
Age 45-55
Age 55-65
Age above 65
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Noden Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Renin-Inhibitors consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Renin-Inhibitors market by identifying its various subsegments.
Focuses on the key global Renin-Inhibitors manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Renin-Inhibitors with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Renin-Inhibitors submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Renin-Inhibitors Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Renin-Inhibitors Consumption 2014-2024
- 2.1.2 Renin-Inhibitors Consumption CAGR by Region
- 2.2 Renin-Inhibitors Segment by Type
- 2.2.1 150mg/Tablet
- 2.2.2 300mg/Tablet
- 2.3 Renin-Inhibitors Consumption by Type
- 2.3.1 Global Renin-Inhibitors Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Renin-Inhibitors Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Renin-Inhibitors Sale Price by Type (2014-2019)
- 2.4 Renin-Inhibitors Segment by Application
- 2.4.1 Age below 45
- 2.4.2 Age 45-55
- 2.4.3 Age 55-65
- 2.4.4 Age above 65
- 2.5 Renin-Inhibitors Consumption by Application
- 2.5.1 Global Renin-Inhibitors Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Renin-Inhibitors Value and Market Share by Application (2014-2019)
- 2.5.3 Global Renin-Inhibitors Sale Price by Application (2014-2019)
3 Global Renin-Inhibitors by Players
- 3.1 Global Renin-Inhibitors Sales Market Share by Players
- 3.1.1 Global Renin-Inhibitors Sales by Players (2017-2019)
- 3.1.2 Global Renin-Inhibitors Sales Market Share by Players (2017-2019)
- 3.2 Global Renin-Inhibitors Revenue Market Share by Players
- 3.2.1 Global Renin-Inhibitors Revenue by Players (2017-2019)
- 3.2.2 Global Renin-Inhibitors Revenue Market Share by Players (2017-2019)
- 3.3 Global Renin-Inhibitors Sale Price by Players
- 3.4 Global Renin-Inhibitors Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Renin-Inhibitors Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Renin-Inhibitors Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Renin-Inhibitors by Regions
- 4.1 Renin-Inhibitors by Regions
- 4.1.1 Global Renin-Inhibitors Consumption by Regions
- 4.1.2 Global Renin-Inhibitors Value by Regions
- 4.2 Americas Renin-Inhibitors Consumption Growth
- 4.3 APAC Renin-Inhibitors Consumption Growth
- 4.4 Europe Renin-Inhibitors Consumption Growth
- 4.5 Middle East & Africa Renin-Inhibitors Consumption Growth
5 Americas
- 5.1 Americas Renin-Inhibitors Consumption by Countries
- 5.1.1 Americas Renin-Inhibitors Consumption by Countries (2014-2019)
- 5.1.2 Americas Renin-Inhibitors Value by Countries (2014-2019)
- 5.2 Americas Renin-Inhibitors Consumption by Type
- 5.3 Americas Renin-Inhibitors Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Renin-Inhibitors Consumption by Countries
- 6.1.1 APAC Renin-Inhibitors Consumption by Countries (2014-2019)
- 6.1.2 APAC Renin-Inhibitors Value by Countries (2014-2019)
- 6.2 APAC Renin-Inhibitors Consumption by Type
- 6.3 APAC Renin-Inhibitors Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Renin-Inhibitors by Countries
- 7.1.1 Europe Renin-Inhibitors Consumption by Countries (2014-2019)
- 7.1.2 Europe Renin-Inhibitors Value by Countries (2014-2019)
- 7.2 Europe Renin-Inhibitors Consumption by Type
- 7.3 Europe Renin-Inhibitors Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Renin-Inhibitors by Countries
- 8.1.1 Middle East & Africa Renin-Inhibitors Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Renin-Inhibitors Value by Countries (2014-2019)
- 8.2 Middle East & Africa Renin-Inhibitors Consumption by Type
- 8.3 Middle East & Africa Renin-Inhibitors Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Renin-Inhibitors Distributors
- 10.3 Renin-Inhibitors Customer
11 Global Renin-Inhibitors Market Forecast
- 11.1 Global Renin-Inhibitors Consumption Forecast (2019-2024)
- 11.2 Global Renin-Inhibitors Forecast by Regions
- 11.2.1 Global Renin-Inhibitors Forecast by Regions (2019-2024)
- 11.2.2 Global Renin-Inhibitors Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Renin-Inhibitors Forecast by Type
- 11.8 Global Renin-Inhibitors Forecast by Application
12 Key Players Analysis
- 12.1 Novartis
- 12.1.1 Company Details
- 12.1.2 Renin-Inhibitors Product Offered
- 12.1.3 Novartis Renin-Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Novartis News
- 12.2 Noden Pharma
- 12.2.1 Company Details
- 12.2.2 Renin-Inhibitors Product Offered
- 12.2.3 Noden Pharma Renin-Inhibitors Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Noden Pharma News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Renin-Inhibitors . Industry analysis & Market Report on Renin-Inhibitors is a syndicated market report, published as Global Renin-Inhibitors Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Renin-Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
